Nature

Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancer

Paracentesis for malignant ascites is usually performed as an in-patient procedure, with a median length of stay (LoS) of 3–5 days, with intermittent clamping of the drain due to a perceived risk of ...
The Trentonian

BD Announces Expanded 510(k) Clearance for At-Home System for Ascites

FRANKLIN LAKES, N.J., June 23, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance from ...
News-Medical.Net

Common cholesterol drug may help disrupt ovarian cancer cell protection

A fluid that women with advanced ovarian cancer know all too well - ascites, the buildup of liquid in the belly - may be ...
FierceBiotech

BD's at-home drainage system lands first FDA nods spanning both cancerous and benign fluid buildup

An apple a day may keep the doctor away, but an at-home catheter system from BD has the potential to keep the entire hospital away. The PeritX system allows patients with ascites to regularly drain ...

A common cholesterol drug may weaken ovarian cancer's hidden shield

Ascites—the buildup of liquid in the belly—may be doing more than causing discomfort. A Duke University School of Medicine ...
ascopubs.org

Continuous low-flow ascites drainage and sequential non-invasive tumor-cell sampling through the urinary bladder via the alfa-pump closed system in platinum-resistant ovarian ...

Validation of urinary HE4 as a biomarker for ovarian cancer. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not include a full text component.
The New England Journal of Medicine

Surgical Treatment of Ascites

ASCITES is a problem frequently encountered and often unsatisfactorily treated. An adjunct in the therapy of ascites has been tried in a limited number of cases and has seemed sufficiently helpful to ...
Nasdaq

BD's (BDX) PeritX System Gets FDA's Expanded 510(k) Clearance

Becton, Dickinson and Company BDX, popularly known as BD, recently announced receipt of the FDA’s 510(k) clearance for its PeritX Peritoneal Catheter System. The system is to be used for the drainage ...
Health.com

Ascites, Explained: From Symptoms to Treatment Options

Ascites often develops as a complication of liver disease, causing fluid buildup in the abdominal cavity. Common treatments for ascites include reducing sodium intake, taking diuretics, and undergoing ...
National Institute for Health and Care Excellence

PeritX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites

You may send us your comments on this form by clicking the button below. You will first be asked to supply your name, email address, and location. You must then acknowledge our data protection ...
National Institute for Health and Care Excellence

PeritX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites

We have moved medical technologies guidance 9 to become HealthTech guidance 282. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme ...